Pharmacokinetic analysis of vancomycin in steady state in pediatric cancer patients

Pediatric Hematology and Oncology

Volumn 15, Issue 4, 1998, Pages 333-338

  Krivoy, Norberto ^a,b   Peleg, Sarit ^a   Postovsky, Sergey ^a   Arush, Miriam Weyl Ben ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Cancer children; Pharmacokinetics; Vancomycin

Indexed keywords

GENTAMICIN; VANCOMYCIN;

ARTICLE; CHILDHOOD CANCER; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG CONCENTRATION; FEMALE; HALF LIFE TIME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MODEL; PLASMA CLEARANCE; PRESCHOOL CHILD; STAPHYLOCOCCUS INFECTION; URINALYSIS;

EID: 0031836683     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019809014017     Document Type: Article

References (20)

1. Fekety R. Vancomycin and teicoplanin. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingtone; 1995:346-354.
2. Leader WG, Chandler MHH, Castiglia M. Pharmacokinetic optimisation of vancomycin therapy. Clin Pharmacokinet. 1995;28:327-342.
3. Lisby-Sutch SM, Nahata MC. Dosage guidelines for the use of vancomycin based on its pharmacokineticsin infants. Eur J Clin Pharmacol. 1988;35:637-642.
4. Asbury WH, Darsey EH, Rose B, Murphy SE, Burrington DE, Capers CC. Vancomycin pharmacokinetics in neonates and infants, a retrospective evaluation. Ann Pharmacother. 1993;27:490-495.
5. Chang D, Liem L, Malogolowkin M. A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients. Pediatr Infect Dis. 1994;13:969-974.
6. Postovsky S, Weil Ben Artish M, Kassis E, Elhasid R, Krivoy N. Pharmacokinetic analysis of gentamicin thrice and single daily dosage in pediatric cancer patients. Pedaitr Hematol Oncol. 1997;14:547-554.
7. Welch LP, Leader G, Chandler MHH. Prediction vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics. Clin Pharmacol. 1993;12:909-912.
8. Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burned patients. JPharmacokinet Biopharmacol. 1976;4:183-195.
9. Sawchuk RJ, Zaske DE, Cippolle RJ, Wargin WA, Strate RG. Kinetic model for gentamicin dosing with the use of individual parameters. Clin Pharmacol Ther. 1976;21:362-369.
10. del Mar Fernandez de Gata M, Fruns I, Hernandez JM, et al. Vancomycin pharmacokinetics and dosage requirements in hematologic malignancies. Clin Pharmacol. 1993;12:515-520.
11. Torres MJ, Kern JW, Gill MA, et al. Comparison of serum gentamicin sampling methods for estimating gentamicin pharmacokinetic variables. Clin Pharmacol. 1983;2:353-355.
12. Le Normand Y, Milpied N, Kergueris MF, Harousseau JL. Pharmacokinetic parameters of vancomycin for therapeutic regimens in neutropenic adults patients. Int J Biomed Comput. 1994;36:121-125.
13. Vaamnuichai M, Day RB, Brater DG. Bayesian and least-squares methods for vancomycin dosing. Am J Med Sci. 1987;294:100-104.
14. Birt JK, Chandler MHH. Using clinical data to determine vancomycin dosing parameters. Ther Drug Monit. 1990;12:206-209.
15. Grenar B, Autret E, Marchand S, Thompson R. Kinetic parameters of amikacin in cystic fibrosis children. Infection. 1987;15:295-299.
16. Kovarik JM, Hoepelman IM, Verhoef J. Once-daily aminoglycoside administration. New strategies for an old drug. Eur J Clin Murobiol Infect Dis. 1989;8:761-769.
17. Ackerman BH, Vannier AM, Eudy EB. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve striping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother. 1992;36:1766-1769.
18. Goetz MB, Sayers J. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. J Antimicrob Chemother. 1993;32:325-334.
19. Fauconneau B, Favreliere S, Pariat C, et al. Nephrotoxicity of gentamicin and vancomycin given alone and in combination as determined by enzymuria and cortical antibiotic levels in rats. Ren Fail. 1997;19:15-22.
20. Reed RL 2d, Wu AH, Miller-Crotchett P, Crotchett J, Fisher RP. Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients. J Trauma. 1989;29:1462-1468.